2016
DOI: 10.2147/ijn.s104198
|View full text |Cite
|
Sign up to set email alerts
|

Facile synthesis of soybean phospholipid-encapsulated MoS2 nanosheets for efficient in vitro and in vivo photothermal regression of breast tumor

Abstract: Two-dimensional MoS 2 nanosheet has been extensively explored as a photothermal agent for tumor regression; however, its surface modification remains a great challenge. Herein, as an alternative to surface polyethylene glycol modification (PEGylation), a facile approach based on “thin-film” strategy has been proposed for the first time to produce soybean phospholipid-encapsulated MoS 2 (SP-MoS 2 ) nanosheets. By simply vacuum-treating MoS … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 36 publications
(42 reference statements)
0
2
0
Order By: Relevance
“…On the other hand, PEGylated MoS 2 nanoflakes were shown to be hemocompatible, causing no hemolysis of isolated RBCs (less than 5% compared to the negative control) (Feng et al, 2015). Experiments performed on human RBCs exposed to MoS 2 nanosheets resulted in a hemolysis ratio under 5%, which is considered comparable to the physiological value (Li et al, 2016). An in vivo experiment on mice treated intravenously with PEGylated MoS 2 NPs showed no disturbances in the RBC count and HCT and HGB levels for up to 60 days of observation (Hao et al, 2017).…”
Section: Hematology and Biochemistrymentioning
confidence: 82%
“…On the other hand, PEGylated MoS 2 nanoflakes were shown to be hemocompatible, causing no hemolysis of isolated RBCs (less than 5% compared to the negative control) (Feng et al, 2015). Experiments performed on human RBCs exposed to MoS 2 nanosheets resulted in a hemolysis ratio under 5%, which is considered comparable to the physiological value (Li et al, 2016). An in vivo experiment on mice treated intravenously with PEGylated MoS 2 NPs showed no disturbances in the RBC count and HCT and HGB levels for up to 60 days of observation (Hao et al, 2017).…”
Section: Hematology and Biochemistrymentioning
confidence: 82%
“…One way to attach biocompatible polymers is by using van der Waals forces. For example, soybean phospholipid, chitosan, poly­(ethylene glycol) (PEG), polyvinyl­pyrrolidone, polyethylenimine (PEI), and F-127 were attached to TMDC nanomaterials via van der Waals forces. ,,, , Another way to conjugate TMDC nanomaterials with biocompatible polymers is through chemical bonds. TMDC nanomaterials can be conjugated with the polymers terminated with lipoic acid groups such as LA-PEG and LA-PEI by forming metal–sulfur bonds. ,, All of these methods require hours or even days of stirring of nanomaterials and biocompatible polymers together.…”
Section: Introductionmentioning
confidence: 99%